Back to results
US 8,618,163 B2Granted
Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
AssigneeAllergan, Inc.
InventorsRichard L. Beard, John E. Donello, Vidyasagar Vuligonda, Michael E. Garst
Life of this patent
Estimating the term…
Abstract
The invention provides well defined compounds having FPRL-1 agonist or antagonist activity. As such, the compounds of the invention are useful for treating a variety of ocular disorders.
Claims8
A compound of the structure:
- wherein:
- a dashed line represents the presence or absence of a bond;
- each R1 is independently H, C1-C6 alkyl, C3-C8 cycloalkyl, or halide;
- R4 is H or C1-C6 alkyl;
- each R5 is independently H, C1-C6 alkyl, cycloalkyl, aryl, fused aryl, alkenyl, alkynyl, halide, hydroxy, alkoxy, trifluoromethyl, acetyl, —OCF3, —SCF3, nitroso, cyano, thioalkyl, —S(O)Me, —S(O)2Me, —S(O)2NH2, or —C(O)OR6, wherein R6 is H or C1-C6 alkyl;
- each X is independently C1-C6 alkyl, C1-C6 alkoxy, or each X taken together forms a cycloalkyl moiety, or each X taken together forms a substituted double bond;
- E1 is O or NH;
- E2 is O or NR7, wherein R7 is H or C1-C6 alkyl;
- n is 0-2;
- m is 0-5;
- and
- p is 1 or 2;
- or pharmaceutically acceptable salts, hydrates, solvates, tautomers, enantiomers, and diastereomers thereof.
10 more elements
Dependencies are inferred from the claim text.